Positive clinical outcomes showcased in poster presentations and satellite
PRINCETON, N.J., June 2 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (OTC Bulletin Board: DSCI), a provider of advanced wound care products, announced today that eleven clinical posters detailing the clinical usage of its newly released MEDIHONEY(TM) Wound & Burn Dressings with Active Leptospermum Honey will be presented at the upcoming 3rd World Union of Wound Healing Societies (WUWHS) conference. This conference, being held in Toronto on June 5-9, takes place every four years and brings together the global thought leaders on advancements in wound care. Additionally, the company has announced that a one-hour satellite symposium will discuss the benefits of Active Leptospermum Honey and its role in advanced wound care.
Chairman and CEO Ed Quilty said, "The clinical outcomes evidence
generated thus far for MEDIHONEY since the product's launch late last year
has been exceptional. It is now becoming clear that the dressings are
beginning to serve an important role as clinicians' first choice for wounds
that have not progressed with standard care, making up roughly 50% of all
chronic wounds. The eleven posters being presented at the WUWHS showcase
the variety of wound types being treated successfully with MEDIHONEY. This
evidence, combined with the satellite symposium, should have great impact
on the conference attendees, and will contribute to the ramp up of global
sales of the product."
The abstracts include the following:
1. "Active Leptospermum Honey Impregnated Calcium Alginate Dressing
Treatment Options for Medically Compromised Patients", Elizabeth Bodie
Gross, RN, NP, WCC.
2. "Wound Healing Experiences using a Honey Based Product", Mary Brennan,
RN, MBA, CWON, Long Island Jewish Medical Center.
3. "Active Leptospermum Honey Impregnated Calcium Alginate Wound Dressing
Facilitates Healing in Elderly Patients with Painful Chronic Wounds
Unable to Tolerate Silver Containing Dressings", Loren Hayes, ARNP-BC,
MS(N), CS-BC, MS, CWCN, CWS, FACCWS, DAPWCA, Wound Technology Network.
4. "Utilizing Active Leptospermum Honey Alginate in the Treatment of
Recalcitrant Lower Extremity Ulcerations", Steven Kavros, DPM, Gonda
Vascular Wound Healing Center, Mayo Clinic.
5. "Favorable Treatment Outcomes of Chronic Leg Ulcers with the Use of a
New Active Leptospermum Honey Alginate Dressing", Dr. Paul A. Ligouri,
MD and Kim L. Peters, RN, CWS, Whittier Rehabilitation Hospital.
6. "A New Active Leptospermum Honey Impregnated Calcium Alginate Dressing
has a Positive Impact on a Wide Variety of Wound Types", Dr. Paul A.
Ligouri, MD and Kim L. Peters, RN, CWS, Whittier Rehabilitation
7. "Chronic Lower Extremity Ulceration - Use of an Active Leptospermum
Impregnated Alginate to Accelerate Wound Closure", Matt Regulski, DPM,
Toms River Foot and Ankle Surgical Associates.
8. "Use of new Active Leptospermum Honey Dressings in Non-healing
Wounds", Becky Strilko, RN, CWOCN, Silver Cross Hospital.
9. "The Challenges of Chronic Venous Leg Ulcers", Kathy Tavernelli,
RN-BC, BSN, CWOCN, Cleveland Clinic Home Care.
10. "The Voice of Experience: Wound Management using Active Leptospermum
Honey Impregnated Alginate Dressings", Dorothy Weir, RN, CWON, CWS,
Director of Wound Healing Center at Osceola Regional Medical Center.
11. "Use of Honey for Wound Healing", Karen Zulkowski, RN, CWOCN, DNsc,
Montana State University.
The Satellite Symposium, taking place on Saturday, June 7 at 12:45 pm, is titled "The Antimicrobial and Wound Healing Effectiveness of Active Leptospermum Honey: Mechanisms of Action and Review of Current Evidence." The symposium will feature a lecture by Dr. Rose Cooper, PhD, Professor in Microbiology, University of Wales Institute, Cardiff, UK, as well as a lecture by Dr. Georgina Gethin, PhD, RGN, DipHE Wound Care Lecturer at the Research Centre of Clinical Nursing and Midwifery, Royal College of Surgeons, Ireland. Dr. Cooper will present information on the mechanisms of action of Active Leptospermum Honey, as well as her findings on activity against biofilms and the inability of organisms to select for resistance. Dr. Gethin will present clinical evidence derived from her randomized controlled study comparing the antimicrobial activity and wound healing effectiveness of Active Leptospermum Honey against a standard advanced wound care dressing, as well as evidence from her study on Active Leptospermum Honey's effect on pH modulation on chronic wounds.
About Derma Sciences
Derma Sciences is a global manufacturer and marketer of advanced wound-care products. Its key product, MEDIHONEY, is sold throughout the world by Derma Sciences and Comvita New Zealand -- the licensor of the patented honey-based technology -- and is the leading brand of honey-based dressings for the management of wounds and burns. The product has been shown to be effective in a variety of wounds and burns, and was recently the focus of a large-scale randomized controlled trial on leg ulcers. Derma has two products in development: the NIMBUS technology based line of barrier gauze dressings, and DSC127, the company's novel angiotensin analog for accelerated wound healing and scar reduction. The barrier technology was licensed from Quick-Med in Q1 of 2007 and is pending its initial FDA marketing clearance. DSC127 was licensed from The University of Southern California in Q4 of 2007 and is entering into a Phase II study, with anticipated initial patient enrollment to begin in Q3 of 2008. For more information about Derma Sciences, Inc., visit its home page on the Internet at http://www.dermasciences.com.
About the WUWHS
The World Union of Wound Healing Societies is a consortium of
associations with a single mission: to enhance the lives of persons with
wounds worldwide. The WUWHS executives includes opinion leaders in wound
care from Australia, Belgium, Canada, France, Denmark, the United Kingdom
and the United States. Wound care professionals from around the world will
attend this congress to appraise information on the latest developments in
wound care, network with and meet colleagues, and share their experiences.
This congress is the most important wound-care meeting in 2008 and will be
attended by health care professionals from all disciplines who have an
interest in wound care. Hosting Societies include The Canadian Association
of Wound Care (CAWC), The Canadian Association of Enterostomal Therapy
(CAET), The Registered Nurses' Association of Ontario (RNAO), The American
Professional Wound Care Association (APWCA), The National Pressure Ulcer
Advisory Panel (NPUAP) and The European Tissue Repair Society (ETRS). The
conference is held every four years. Prior locations have been Australia
Contact: Derma Sciences, Inc. Allen & Caron Inc
Edward J. Quilty Rudy Barrio (US Investors)
Chairman and CEO firstname.lastname@example.org
(609) 514-4744 Brian Kennedy (media)
|SOURCE Derma Sciences, Inc.|
Copyright©2008 PR Newswire.
All rights reserved